Patent: 9,016,221

Summary for Patent: 9,016,221

Title:	Surface topographies for non-toxic bioadhesion control
Abstract:	Disclosed herein is an article that includes a first plurality of spaced features. The spaced features are arranged in a plurality of groupings; the groupings of features include repeat units; the spaced features within a grouping are spaced apart at an average distance of about 1 nanometer to about 500 micrometers; each feature having a surface that is substantially parallel to a surface on a neighboring feature; each feature being separated from its neighboring feature; the groupings of features being arranged with respect to one another so as to define a tortuous pathway. The plurality of spaced features provide the article with an engineered roughness index of about 5 to about 20.
Inventor(s):	Brennan; Anthony B. (Gainesville, FL), Long; Christopher James (Titusville, FL), Bagan; Joseph W. (Greenwood Village, CO), Schumacher; James Frederick (Cumming, GA), Spiecker; Mark M. (Denver, CO)
Assignee:	University of Florida Research Foundation, Inc. (Gainesville, FL)
Application Number:	12/550,870
Patent Claims:	see list of patent claims

Details for Patent 9,016,221

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Abbvie Inc.	SURVANTA	beractant	Suspension	020032	07/01/1991		2024-02-17
Microbix Biosystems Inc.	KINLYTIC	urokinase	For Injection	021846	01/16/1978		2024-02-17
Recordati Rare Diseases, Inc.	ELSPAR	asparaginase	For Injection	101063	01/10/1978		2024-02-17
Servier Pharmaceuticals Llc	ONCASPAR	pegaspargase	Injection	103411	02/01/1994		2024-02-17
Janssen Biotech, Inc.	REOPRO	abciximab	Injection	103575	12/22/1994		2024-02-17
Genentech, Inc.	RITUXAN	rituximab	Injection	103705	11/26/1997		2024-02-17
Idec Pharmaceuticals Corp.	RITUXAN	rituximab	Injection	103737	02/19/2002		2024-02-17